Drug recall · October 5, 2022
Neoral soft gelatin capsules recall
Why: CGMP deviations: Out of specification results obtained during routine stability testing for ethanol content.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Neoral soft gelatin capsules (cyclosporine capsules, USP) Modified, 25 mg, Rx Only, 30 Soft Gelatin Capsules per carton, Mfg by: Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, NDC # 0078-0246-15.
- Lots / codes
Lot # APCD162, Exp. 01/2023
- Quantity
- 132,999 cartons
- Company
- Novartis Pharmaceuticals Corporation, East Hanover, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- September 16, 2022 · Voluntary: Firm initiated
- Classified
- September 26, 2022
- Reported
- October 5, 2022
- Ended
- March 11, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Neoral
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.